Related Experiment Video
Updated: Jul 9, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose
X A Li1, J Z Wang, R D Stewart
1Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. ali@radonc.mcw.edu
The British Journal of Radiology
|November 28, 2007
Summary
This study determined alternative radiotherapy regimens biologically equivalent to standard treatments for prostate cancer. It provides options for hypofractionation, brachytherapy, and combined approaches, aiding in clinical trial design.
Area of Science:
- Radiation Oncology
- Medical Physics
- Clinical Research
Background:
- Standard radiotherapy (RT) regimens for localized prostate cancer are well-established but exploring alternative fractionation schemes and modalities is crucial for optimizing treatment.
- Biological equivalence allows for the comparison of different RT approaches, ensuring comparable therapeutic outcomes while potentially reducing toxicity or treatment time.
Purpose of the Study:
- To determine alternative radiotherapy regimens that are biologically equivalent to established treatments for localized prostate cancer.
- To provide a framework for comparing different RT modalities and fractionation schedules using the linear quadratic model and equivalent uniform dose (EUD).
Main Methods:
- Utilized the linear quadratic model and the concept of equivalent uniform dose (EUD) to calculate biologically equivalent RT regimens.
- Incorporated two distinct sets of radiobiological parameters (alpha/beta ratios of 3.1 Gy and 1.5 Gy) derived from clinical data.
- Accounted for dose inhomogeneities using representative dose-volume histograms for various RT modalities.
Main Results:
- Generated a series of alternative and equivalent fractionation regimens for localized prostate cancer, considering different RT modalities (e.g., external beam RT, brachytherapy).
- Provided specific examples of biologically equivalent regimens, such as hypofractionated external beam RT, I-125 implants, Pd-103 implants, and high-dose-rate brachytherapy, compared to a standard 76 Gy EBRT regimen.
- Calculated EUD values for the rectum to assess potential toxicity for critical structures.
Conclusions:
- The study presents data on biologically equivalent RT regimens that can inform the design of clinical trials for localized prostate cancer.
- These findings may facilitate the exploration of novel RT strategies, including image-guided intensity-modulated RT and hypofractionated approaches.
- The calculated regimens offer flexibility in treatment planning, potentially leading to improved therapeutic ratios in prostate cancer management.
Related Concept Videos
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...